Ovarian Mucinous Adenocarcinoma (DBCOND0030564)

Identifiers

Synonyms

Mucinous Adenocarcinoma of Ovary

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05500391	Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring	No drug interventions	health_services_research	2	recruiting
NCT01167712	Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer	Bevacizumab Carboplatin Paclitaxel	treatment	3	active_not_recruiting
NCT02834013	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors	Ipilimumab Nivolumab	treatment	2	active_not_recruiting
NCT00719303	Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	No drug interventions	prevention	3	unknown_status
NCT03641287	The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors	No drug interventions	supportive_care	Not Available	terminated
NCT05498597	AMT-151 in Patients With Selected Advanced Solid Tumours	No drug interventions	treatment	1	recruiting
NCT01074411	Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Bortezomib Bortezomib D-mannitol Carboplatin	treatment	1	completed
NCT00888615	Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Elesclomol Paclitaxel	treatment	2	completed
NCT00951496	Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Bevacizumab Carboplatin Chloride ion Cisplatin Paclitaxel Platinum	treatment	3	completed
NCT02923739	Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Bevacizumab Emactuzumab Paclitaxel	treatment	2	terminated
NCT01504126	Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	Propranolol	treatment	0	completed
NCT01097746	First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer	Bevacizumab Carboplatin Paclitaxel	treatment	2	completed
NCT00989651	Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer	Bevacizumab Carboplatin Chloride ion Cisplatin Paclitaxel Platinum Veliparib	treatment	1	completed
NCT00262847	Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer	Bevacizumab Carboplatin Paclitaxel	treatment	3	completed
NCT00108745	Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer	Glutamic acid Paclitaxel Paclitaxel poliglumex	treatment	3	unknown_status
NCT02020707	Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers	Albumin human Bevacizumab Paclitaxel	treatment	1	completed
NCT05415709	Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer	Carboplatin Chloride ion Cisplatin Paclitaxel Platinum	treatment	0	recruiting
NCT02364713	MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer	Bevacizumab Doxorubicin Gemcitabine Measles virus vaccine live attenuated Paclitaxel Sodium iodide Tetracycline Topotecan	treatment	2	active_not_recruiting
NCT02853318	Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Bevacizumab Cyclophosphamide Pembrolizumab	treatment	2	completed
NCT02068794	MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer	Measles virus vaccine live attenuated Sodium iodide	treatment	1 / 2	active_not_recruiting